| Literature DB >> 34484328 |
Ying-Hao Song1,2, Ruo-Xin Xu3, Yong Zhang2, Meng-Xuan Xing2,4, Li-Dong Xu2, Kun-Kun Li2, Xing-Guo Xiao2, Lu Li2, Yan-Jing Xiao5, Yu-Lei Qu1, Ying-Jie Ma1, Bao-Hui Jia6, Hui-Li Wu2.
Abstract
BACKGROUND AND AIMS: Magnifying chromoendoscopy (ME-CE) through the observation of pit patterns is a productive way to distinguish between neoplastic and nonneoplastic polyps. Magnifying optical enhancement technology (ME-OE) is an emerging virtual chromoendoscopy imaging technology and appeared to be a promising approach. However, this information is currently not available. This study is aimed at comparing the differential diagnostic value of ME-CE and OE for neoplastic and nonneoplastic polyps. Patients and Methods. Consecutive patients undergoing colonoscopy were randomized (1 : 1) into examination by ME-OE or ME-CE. Histopathological findings were utilized as the reference standard. Accuracy, sensitivity, specificity, and positive and negative predictive values of two endoscopy methods were compared using ME-OE (were classified according to the JNET classification) and ME-CE (were classified according to the Kudo pit pattern classification), respectively, and the time to predict the histological polyp type was compared. And the agreements between the pathological and clinical diagnosis by ME-OE or ME-CE were analyzed.Entities:
Year: 2021 PMID: 34484328 PMCID: PMC8416392 DOI: 10.1155/2021/5533657
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Figure 1Endoscopic images in the magnifying mode: (a) nonneoplastic polyps (JNET type 1); (b) neoplastic polyps (JNET type 2A); (c) nonneoplastic polyps (pit pattern types I); (d) neoplastic polyps (pit pattern type IV).
Figure 2Flow chart of the examinations: 519 patients enrolled, 220 patients eligible (299 patients excluded: no polyps: n = 111, coagulation disorders: n = 92, inadequate bowel preparation: n = 43, melanosis coli: n = 20, previous colon resection: n = 24, polyposis syndrome: n = 5, and incomplete colonoscopy: n = 4).
Clinical characteristics of the subject subjects.
| ME-OE | ME-CE | Overall | ||
|---|---|---|---|---|
| Number | 110 | 110 | 220 | NA |
| Gender (M/F) | 56/54 | 53/57 | 109/111 | 0.686 |
| Age (mean ± SD) (y) | 48.8 ± 14.1 | 51.7 ± 14.3 | 50.3 ± 14.2 | 0.121 |
| Indication | 0.154 | |||
| Screening | 21 | 14 | 35 | |
| Symptoms | 43 | 34 | 77 | |
| Surveillance | 23 | 35 | 58 | |
| Examination | 23 | 27 | 50 | |
| Bowel cleansing (BBPS) | 0.08 | |||
| 6/7 | 7/17 | 6/32 | 13/49 | |
| 8/9 | 47/39 | 34/38 | 81/77 | |
ME-CE: magnifying chromoendoscopy; ME-OE: magnifying optical enhancement technology; BBPS: Boston Bowel Preparation Scale; NA: not applicable; SD: standard deviation.
Descriptive per-polyp analysis.
| ME-OE (%) | ME-CE (%) | Overall (%) | ||
|---|---|---|---|---|
| Number | 185 | 180 | 365 | NA |
| Size (mm) | 0.157 | |||
| ≤5 | 104 (56.2) | 119 (66.1) | 223 (61.1) | |
| 5-10 | 76 (41.1) | 58 (32.2) | 134 (36.7) | |
| ≥10 | 5 (2.7) | 3 (1.7) | 8 (2.2) | |
| Location | 0.389 | |||
| Right side of colon | 73 (39.5) | 64 (35.6) | 137 (37.5) | |
| Transverse colon | 35 (18.9) | 26 (14.4) | 61 (16.7) | |
| Descending colon | 40 (21.6) | 44 (24.4) | 84 (23.1) | |
| Sigmoid colon/rectum | 37 (20.0) | 46 (25.6) | 83 (22.7) | |
| Morphology | 0.064 | |||
| Ip | 23 (12.5) | 33 (18.3) | 56 (15.3) | |
| Is | 62 (33.5) | 73 (40.6) | 135 (37.0) | |
| IIa | 77 (41.6) | 61 (33.9) | 138 (37.8) | |
| IIb | 23 (12.4) | 13 (7.2) | 36 (9.9) | |
| Histology | 0.120 | |||
| Nonneoplastic | 95 (51.4) | 107 (59.4) | 202 (55.3) | |
| Size (mean ± SD) (mm) | 3.1 ± 1.1 | 3.3 ± 1.2 | 3.2 ± 1.1 | |
| Neoplastic | 90 (48.6) | 73 (40.6) | 163 (44.7) | |
| Size (mean ± SD) (mm) | 5.9 ± 1.7 | 5.8 ± 1.4 | 5.8 ± 1.6 | |
| Time (mean ± SD) (s) | 83 ± 26.4 | 194 ± 17.7 | 138 ± 60.2 | 0.001 |
ME-CE: magnifying chromoendoscopy; ME-OE: magnifying optical enhancement technology; NA: not applicable; SD: standard deviation.
Diagnostic accuracy and time in two methods.
| Overall | ME-OE | ME-CE | ||||
|---|---|---|---|---|---|---|
| ME-OE | ME-CE | Stage 1 | Stage 2 | Stage 1 | Stage 2 | |
| Sensitivity (%) | 91 | 85 | 96 | 90 | 87 | 84 |
| Specificity (%) | 95 | 96 | 85 | 1 | 93 | 98 |
| PPV (%) | 94 | 94 | 86 | 1 | 93 | 96 |
| NPV (%) | 92 | 90 | 95 | 93 | 88 | 92 |
| Accuracy (%) | 93 | 92 | 90 | 96 | 90 | 93 |
| 0.639 | 0.145 | 0.418 | ||||
|
| 0.859 | 0.827 | 0.804 | 0.912 | 0.800 | 0.848 |
| Time (mean ± SD) (s) | 83 ± 26.4 | 194 ± 17.7 | 96 ± 26.8 | 70 ± 19.0 | 205 ± 13.9 | 183 ± 14.0 |
| 0.001 | 0.001 | 0.001 | ||||
PPV: positive predictive value; NPV: negative predictive value; ME-CE: magnifying chromoendoscopy; ME-OE: magnifying optical enhancement technology; SD: standard deviation.
Diagnostic accuracy and time in two stages.
| Overall | Stage 1 | Stage 2 | ||||
|---|---|---|---|---|---|---|
| ME-OE | ME-CE | ME-OE | ME-CE | ME-OE | ME-CE | |
| Sensitivity (%) | 91 | 85 | 96 | 87 | 0.90 | 84 |
| Sensitivity (%) | 95 | 96 | 85 | 93 | 1 | 98 |
| PPV (%) | 94 | 94 | 86 | 93 | 1 | 96 |
| NPV (%) | 92 | 90 | 95 | 88 | 93 | 92 |
| Accuracy (%) | 93 | 92 | 90 | 90 | 96 | 93 |
| 0.639 | 0.961 | 0.705 | ||||
|
| 0.859 | 0.827 | 0.804 | 0.800 | 0.912 | 0.848 |
| Times (mean ± SD) (s) | 83 ± 26.4 | 194 ± 17.7 | 96 ± 26.8 | 205 ± 13.9 | 70 ± 19.0 | 183 ± 14.0 |
| 0.001 | 0.001 | 0.001 | ||||
PPV: positive predictive value; NPV: negative predictive value; ME-CE: magnifying chromoendoscopy; ME-OE: magnifying optical enhancement technology; SD: standard deviation.